logo-loader
viewXphyto Therapeutics Corp.

XPhyto Therapeutics signs new research agreement with leading German university

XPhyto's German subsidiary Bunker has entered into an exclusive agreement with the Technical University of Munich’s biochemistry department to research novel approaches to utilize cannabis

Xphyto Therapeutics Corp. - XPhyto Therapeutics signs new research agreement with leading German university
XPhyto and TUM will advance any promising targets through pilot studies and pursue research projects on a case-by-case basis

XPhyto Therapeutics Corp (CSE:XPHY) (FSE:4XT) has signed a new agreement in Germany that will enhance the science-focused cannabis company’s research and development initiatives.

The Vancouver-based company announced Wednesday that it had entered into an exclusive agreement with the Technical University of Munich’s biochemistry department to research novel approaches to utilize the cannabis plant and its derivatives.

The cannabis company’s German subsidiary, Bunker Pflanzenextrakte GmbH, will carry out the agreement with the Technical University of Munich (TUM).

READ: Xphyto Therapeutics shares begin trading on the Frankfurt Stock Exchange

XPhyto and TUM will advance any promising targets through pilot studies and pursue research projects on a case-by-case basis to explore potential commercialization.

Robert Barth, XPhyto's vice president, European corporate development and Bunker’s managing director, hailed TUM’s leading reputation in Europe.

"XPhyto is honored to have the privilege of working with TUM. Their commitment to research excellence and their reputation for commercial development makes them a highly attractive partner," Barth said in a statement.

"TUM's strong interest in cannabis research demonstrates a progressive attitude toward an emerging and highly relevant global industry."

The German university is the only technical university in the country to be recognized as a “University of Excellence” each year since the program began in 2006.

Earlier this week XPhyto shares sprang to life on the Frankfurt Stock Exchange, making the company dual-listed in both Canada and Germany.

XPhyto’s shares were trading at C$1.33 in Toronto on Wednesday morning.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Xphyto Therapeutics Corp.

Price: 1.24 CAD

CSE:XPHY
Market: CSE
Market Cap: $58.41 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Xphyto Therapeutics Corp. named herein, including the promotion by the Company of Xphyto Therapeutics Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks start slow but Nextleaf picks up steam on...

Cannabis stocks had a slow start to Monday, with shares broadly flat across US and Canadian markets.  The North American Marijuana Index was down 0.8% at 189.9 points. Elsewhere, the OTCQX Cannabis Index inched up 0.1% at 687.5 points. Buds...

on 9/9/19

2 min read